SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-004270
Filing Date
2021-11-12
Accepted
2021-11-12 08:31:04
Documents
71
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q lyel-20210930.htm   iXBRL 10-Q 3053757
2 EX-31.1 lyel-ex31_1.htm EX-31.1 18218
3 EX-31.2 lyel-ex31_2.htm EX-31.2 18226
4 EX-32.1 lyel-ex32_1.htm EX-32.1 10395
5 EX-32.2 lyel-ex32_2.htm EX-32.2 10911
6 GRAPHIC img213714780_0.jpg GRAPHIC 54053
  Complete submission text file 0000950170-21-004270.txt   10081106

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lyel-20210930_lab.xml EX-101.LAB 492169
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lyel-20210930_cal.xml EX-101.CAL 46320
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lyel-20210930.xsd EX-101.SCH 58097
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lyel-20210930_def.xml EX-101.DEF 247435
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lyel-20210930_pre.xml EX-101.PRE 399453
12 EXTRACTED XBRL INSTANCE DOCUMENT lyel-20210930_htm.xml XML 1787785
Mailing Address 201 HASKINS WAY SOUTH SAN FRANCISCO CA 94080
Business Address 201 HASKINS WAY SOUTH SAN FRANCISCO CA 94080 650 695-0677
Lyell Immunopharma, Inc. (Filer) CIK: 0001806952 (see all company filings)

IRS No.: 833006753 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40502 | Film No.: 211399931
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences